L Pyle
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 10
-
- Protein Degradation and Inhibitors 3
- Renal and related cancers 2
- Co-authors
- Martin Gore (10 shared papers)Tim Eisen (6 shared papers)Roger A’Hern (5 shared papers)Ian Mak (5 shared papers)Francisco Sapunar (3 shared papers)Matthew Vaughan (2 shared papers)Stephen R.D. Johnston (2 shared papers)IE Smith (1 shared paper)
- Journals
- British Journal of Cancer (6 papers)Journal of Clinical Oncology (3 papers)Journal of Immunotherapy (1 paper)The Oncologist (1 paper)The Lancet (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
L Pyle
17 papers receiving 829 citations
Peers
Comparison fields: 5 of 71
- Hematology 140
- Pulmonary and Respiratory Medicine 341
- Cancer Research 155
- Oncology 251
- Molecular Biology 353
Countries citing papers authored by L Pyle
This map shows the geographic impact of L Pyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Pyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Pyle more than expected).
Fields of papers citing papers by L Pyle
This network shows the impact of papers produced by L Pyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Pyle. The network helps show where L Pyle may publish in the future.
Co-authors
The 25 scholars most cited alongside L Pyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 291 | |
| 2 | 2012 | 170 | |
| 3 | 2001 | 94 | |
| 4 | 2010 | 78 | |
| 5 | 2004 | 44 | |
| 6 | 2004 | 40 | |
| 7 | 2002 | 32 | |
| 8 | 2004 | 22 | |
| 9 | 2010 | 21 | |
| 10 | 2006 | 17 | |
| 11 | 2017 | 15 | |
| 12 | 2001 | 10 | |
| 13 | 1997 | 9 | |
| 14 | Functional adrenocortical carcinoma in a dog. | 1967 | 7 |
| 15 | 2005 | 4 | |
| 16 | 2012 | 1 | |
| 17 | 1999 | 1 |
About L Pyle
L Pyle is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Hematology, having authored 17 papers that have together received 856 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Cancer Genomics and Diagnostics (3 papers), Protein Degradation and Inhibitors (3 papers), Multiple Myeloma Research and Treatments (3 papers), Cutaneous Melanoma Detection and Management (3 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Hematology (140 citations), Pulmonary and Respiratory Medicine (341 citations), Cancer Research (155 citations), Oncology (251 citations) and Molecular Biology (353 citations). L Pyle has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Martin Gore, Tim Eisen, Roger A’Hern, Ian Mak, Francisco Sapunar, Matthew Vaughan, Stephen R.D. Johnston, IE Smith, Chris Boshoff and Peter F.A. Mulders. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Journal of Immunotherapy, The Oncologist and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.